申请人:Phusis Therapeutics, Inc.
公开号:US20160304533A1
公开(公告)日:2016-10-20
Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.